Genomic Study of Cervical Cancer Identifies Potential Treatment TargetsJanuary 28th 2014
Researchers have completed a comprehensive genomic analysis of cervical cancer in two patient populations. The study identified recurrent genetic mutations not previously found in cervical cancer, including one for which targeted agents have been approved in other cancers.
DOHH-Inhibiting Drugs Reduce Proliferation of Cervical Cancer CellsJanuary 24th 2014
Two drugs that inhibit deoxyhypusine hydoxylase (DOHH) may show promise as potential treatments for cervical cancer, according to research from scientists at Rutgers New Jersey Medical School.
NY-ESO-1 Antigen Spreading With Decitabine Increases Immunotherapy ResponseJanuary 23rd 2014
Treatment with decitabine prior to administration of chemotherapy and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, suggesting that this combinatorial chemoimmunotherapy may provide a new treatment option.
PD-1 and PD-L1 Inhibitors Show Dramatic Response Rates in NSCLCJanuary 22nd 2014
The future of PD-1 and PD-L1 inhibition in non-small cell lung cancer (NSCLC) is bright, with ongoing studies suggesting that the strategy will lead to a â€œnew worldâ€ in the treatment of the disease.